Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
Antoine RegnaultThomas MorelChristine de la LogeFlora MazerolleHenry J KaminskiThomas H BrannaganPublished in: Neurology and therapy (2023)
ClinicalTrials.gov identifier: NCT03052751.
Keyphrases